scholarly journals Selection and treatment of patients for transcatheter aortic valve implantation through a day hospital: a case report

2021 ◽  
Vol 16 (11-12) ◽  
pp. 366-366
Author(s):  
Matija Vrbanić ◽  
Kristijana Radić ◽  
Ivica Benko ◽  
Ljiljana Švađumović ◽  
Vlatka Funduk ◽  
...  
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Day Hospital ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Acute myocardial infarction associated with prosthetic valve leaflet thrombosis after transcatheter aortic valve implantation: a case report

2020 ◽  
Author(s):  
Johannes Rotta Detto Loria ◽  
Holger Thiele ◽  
Mohamed Abdel-Wahab
Keyword(s):  
Myocardial Infarction ◽  
Case Report ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Prosthetic Valve ◽  
Valve Leaflet ◽  
Transcatheter Aortic Valve ◽  
Valve Function ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract Background Fatal thrombo-embolic events like cerebral stroke or myocardial infarction are rare complications of prosthetic heart valve leaflet thrombosis. Nevertheless, prevention and management of leaflet thrombosis is gaining increased attention, particularly with the widespread adoption of transcatheter heart valves. Case summary We herein present the case of a 79-year-old man who had undergone a transcatheter aortic valve implantation procedure. Seven months later, he presented with a non-ST-segment elevation myocardial infarction. Coronary angiography did not reveal obstructive lesions. A dedicated cardiac computed tomography scan showed thrombosis of both right- and non-coronary leaflets of the prosthetic aortic valve, while prosthetic valve function was normal on echocardiography. Transmural myocardial infarction lesions in the midventricular and apical inferior wall were detected by cardiac magnetic resonance imaging. Discussion Subclinical leaflet thrombosis of prosthetic aortic valves is a common finding. In this case report, we show that myocardial infarction presumably due to leaflet thrombosis was the first symptom in an otherwise asymptomatic patient. This finding raises the question of the validity in distinguishing between subclinical and clinical leaflet thrombosis based on prosthetic valve function.

scholarly journals A case report: black oesophagus as a possible complication of transcatheter aortic valve implantation

2019 ◽  
Vol 3 (2) ◽  
Author(s):  
Inês S Gonçalves ◽  
Armando L Bordalo e Sá ◽  
Narcisa Fatela ◽  
Pedro Canas da Silva
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
High Rate ◽  
Haemodynamic Instability ◽  
Heart Team ◽  
Transcatheter Aortic Valve ◽  
Acute Necrotizing ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract Background The increasing number of transcatheter aortic valve implantation (TAVI) in the last few years has unveiled a unique set of events and complications that need prompt recognition and management in order to improve patient outcomes, often involving a multidisciplinary team. Case summary We present a case of a 86-year-old woman with symptomatic severe aortic stenosis that underwent a TAVI and, in the post-procedure period, presented with acute abundant haematemesis, haemodynamic instability, and haemoglobin drop. The diagnosis of acute necrotizing oesophagitis (ANE) was made by upper gastrointestinal endoscopy. Discussion Acute necrotizing oesophagitis is a rare entity caused usually by an ischaemic insult in the presence of predisposing factors; it has a high rate of complications and mortality. To the best of our knowledge, this is the first clinical case report to describe the occurrence of ANE as a possible complication of TAVI and is also an example of the importance of the multidisciplinary approach of these complex patients, which extends even beyond the concept of Heart Team.

scholarly journals Transcatheter aortic valve implantation after aortic valve neocuspidization using autologous pericardium: a case report

2019 ◽  
Vol 3 (3) ◽  
Author(s):  
Norio Tada ◽  
Naoyuki Tanaka ◽  
Kazuo Abe ◽  
Masaki Hata
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Open Heart Surgery ◽  
Autologous Pericardium ◽  
Transcatheter Aortic Valve ◽  
Structural Deterioration ◽  
Transcatheter Heart Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract Background Aortic valve neocuspidization (AVNeo), a novel surgical procedure used in the treatment of aortic valve diseases, including aortic stenosis (AS), involves the replacement of three aortic valve cusps by glutaraldehyde-treated autologous pericardium. Although reoperation risk is low, no case report on the deterioration of the AVNeo has yet been published. Case summary An 80-year-old woman who underwent AVNeo for severe degenerative tricuspid AS 6 years previously complained of shortness of breath. Echocardiographic assessment revealed the reconstructed aortic valve leaflet was elongated, thickened, and marginally calcified resulting in recurrent severe AS. Transcatheter aortic valve implantation using balloon-expandable transcatheter heart valve was successfully performed. Discussion To our knowledge, this is the first case report regarding the structural deterioration of the AVNeo resulting in restenosis 6 years after the first surgery. Transcatheter aortic valve implantation is possibly a suitable approach for post-procedural recurrence after AVNeo to avoid redo open-heart surgery which would be of prohibitive risk especially in an elderly population.

scholarly journals P863 Large pericardial effusion two months after transcatheter aortic valve implantation: case report of a post-cardiac injury syndrome

2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
R Alves Pinto ◽  
M Martins Carvalho ◽  
T Proenca ◽  
P M Araujo ◽  
A Nunes ◽  
...  
Keyword(s):  
Case Report ◽  
Pericardial Effusion ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Inflammatory Markers ◽  
Cardiac Injury ◽  
Transcatheter Aortic Valve ◽  
Large Pericardial Effusion ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract We present a case of a 87-year-old female with a symptomatic severe aortic stenosis (aortic valve area 0.9 cm2, mean transvalvular pressure gradient 44 mmHg). She was refused to surgical aortic valve replacement due to marked aortic root calcification. A transcatheter aortic valve (ACCURATE neo™ 27) was electively implanted. In immediate post-procedure, the patient presented an episode of hypotension, rapidly reverted with supportive treatment. A transthoracic echocardiogram (TTE) showed a circumferential mild pericardial effusion (PE) without prosthetic valve disfunction and with preserved biventricular systolic function. Due to paroxysmal episodes of atrial fibrillation, it was decided to withdraw anti-aggregation and to start anticoagulation. Four days after transcatheter aortic valve implantation (TAVI) the patient presented newer intraventricular and atrioventricular conduction disturbance (left bundle branch block and type-I second-degree atrioventricular block). A definitive pacemaker was implanted without complications. PE maintained stable and seven days after TAVI the patient was discharged from hospital. Two months after TAVI, the patient was admitted to Intensive care unit (ICU) with increasing asthenia, dyspnea and pleuritic thoracic pain over the preceding two weeks. Laboratory workup exhibited elevation of inflammatory markers (leukocytosis and C-reactive protein). A TTE was performed and showed a large circumferential PE (29 mm) with signs of hemodynamic impact (swinging heart, inferior vena cava dilation with <50% inspiratory collapse, right atrial collapse >1/3 of cardiac cycle, proto-diastolic right ventricular collapse and mitral respiratory flow variation >25%). The patient started treatment with anti-inflammatory drugs (aspirin 1000mg every 8h plus colchicine 0.5mg twice daily) and pericardiocentesis was initially postponed. In spite of clinical and echocardiographic improvement, she maintained elevated inflammatory markers and a moderate PE. Prednisolone 30mg daily was added to initial therapy and serial evaluations showed a pronounced reduction of PE as well as of inflammatory markers. Two weeks after admission to ICU the patient was discharged with a residual PE measuring less than 5mm. The previous recent cardiac intervention and the effective response to anti-inflammatory treatment suggest a post-cardiac injury syndrome. This case report wants to show that post-cardiac injury syndrome is a diagnosis that should be keep in mind after TAVI. Abstract P863 Figure. TTE showing large pericardial effusion

Sign in / Sign up

Export Citation Format

Share Document